Vaccine Marketing - Innovation and Marketing in the Pharmaceutical Industry - page 406

Health data is estimated at 70 % for the US, between 50 and 90 % for Western
European countries, and less than 20 % for China.
Because of the lack of reliable syndicated sales data, companies like Sanofi
Pasteur have developed their own complex data collection system which combines
data from multiple sources.

13.8 Conclusion

In 2010, the Bill & Melinda Gates Foundation declared this decade “The Decade of
Vaccines.” Not long ago perceived as an unattractive segment of the pharmaceutical
industry, most of the leading fi rms have revised their opinion and increased their
investments in vaccines. In preparing this chapter, we have found very few articles
dealing with vaccines in the marketing literature. We hope that marketing academ-
ics will follow the lead of the pharmaceutical industry and devote more attention to
vaccines during this decade.

References

Aaker DA (2004) Brand portfolio strategy. Free Press, New York, NY
Abrevaya J, Mulligan K (2011) Effectiveness of state-level vaccination mandates: evidence from
the varicella vaccine. J Health Econ 30(5):966-976
Adult Immunization Working Group to the National Vaccine Advisory Committee (2011) Adult
immunization: complex challenges and recommendations for improvement. Draft report v2.0.
http://www.hhs.gov/nvpo/nvac/subgroups/wg_report_v2_25feb2011.pdf . Accessed 22 Aug 2011
Ajzen I (1988) Attitudes, personality, and behavior. Dorsey, Chicago, IL
Ajzen I (1991) The theory of planned behavior. Organ Behav Hum Decis Process 50:179-211
Ajzen I, Fishbein M (2005) The infl uence of attitudes on behavior. In: Albarracin D, Johnson BT,
Zanna MP (eds) The handbook of attitudes. Lawrence Erlbaum, Mahwah, NJ, pp 173-221
Allen JD, Mohllajee AP, Shelton RC, Othus MKD, Fontenot HB, Hanna R (2009) Stage of adop-
tion of the human papillomavirus vaccine among college women. Prev Med 48(5):420-425
Allen JD, Othus MK, Shelton RC, Li Y, Norman N, Tom L et al (2010) Parental decision making
about the HPV vaccine. Cancer Epidemiol Biomarkers Prev 19(9):2187-2198
Andrews M (2011) GSK vaccines in 2011. http://www.gsk.com/content/dam/gsk/globals/docu-
ments/pdf/Investors/presentations/2011/2011-03-23-martin-andrews-citi.pdf . Accessed 4 July
2013
Angelmar R, Angelmar S, Kane L (2007) Building strong condition brands. J Med Mark
7(4):341-351
Anonymous (2010) Fighting swine fl u fatigue with weird marketing: offi cials try human bill-
boards, night club promotions to spark interest. Associated Press. http://www.msnbc.msn.com/
id/35467666/ns/health-cold_and_fl u/t/fi ghting-swine-fl u-fatigue-weird-marketing/# . Accessed
28 Aug 2011
Anonymous (2011) Background information to GAVI alliance's draft vaccine supply and procure-
ment strategy for the period 2011-2015. http://www.gavialliance.org/library/gavi-documents/
supply-procurement/ . Accessed 26 Aug 2011
Applebaum M (2007) Life gard. Brandweek 48(36):34-37
Appleby J (2004) Nasal FluMist overcomes obstacles to reach public. USA Today, 6 Jan